Sunday, February 16, 2025

Venture Global, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

 ARLINGTON, Va. - Saturday, 15. February 2025 AETOSWire Print 


(BUSINESS WIRE)--Venture Global, Inc. (“Venture Global”) (NYSE: VG) announced today that it plans to issue its earnings release with respect to fourth quarter and full year 2024 financial results before market open on Thursday, March 6, 2025.


Venture Global will host a conference call for investors and analysts beginning at 9:00 am Eastern Time (ET) on March 6, 2025, to discuss fourth quarter and full year results and provide guidance for the 2025 fiscal year.


A listen-only webcast of the call and accompanying slide presentation will be available at Venture Global’s Investor Relations website HERE. After the conclusion of the webcast, a replay will be made available on the Venture Global website.


About Venture Global


Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets across the LNG supply chain including LNG production, natural gas transport, shipping and regasification. Venture Global’s first facility, Calcasieu Pass, commenced producing LNG in January 2022. The company’s second facility, Plaquemines LNG, achieved first production of LNG in December 2024. The company is currently constructing and developing over 100 MTPA of nameplate production capacity to provide clean, affordable energy to the world. Venture Global is developing Carbon Capture and Sequestration projects at each of its LNG facilities.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20250214771737/en/



Permalink

https://www.aetoswire.com/en/news/20250214771737r1


Contacts

 

Investor Contacts:

Michael Pasquarello

IR@venturegloballng.com


Media Contacts:

Shaylyn Hynes

Press@venturegloballng.com

Saturday, February 15, 2025

Elon Musk Talks ‘Tech Support’ Governance as World Leaders Champion Innovation-Driven Reforms at Dubai Summit

 DUBAI, United Arab Emirates - Friday, 14. February 2025


(BUSINESS WIRE)--Wearing a “Tech Support”-printed T-shirt, Elon Musk virtually took to the stage on the final day of the World Governments Summit in a live discussion with H.E. Omar Sultan Al Olama, UAE Minister of State for Artificial Intelligence, Digital Economy, and Remote Work Applications, to share his vision for improving government efficiency.


Musk emphasized the urgency of streamlining operations, advocating for smaller, more accountable institutions to drive efficiency and economic growth.


The World Governments Summit, held in Dubai from February 11-13, brought together global leaders and experts to address critical challenges in governance, healthcare, and trade in the 21st century.


Now in its 12th edition, the Summit unveiled a suite of insights, key results, and actionable solutions developed by top policymakers, innovators, and thought leaders from around the world.


Musk stated: “We have the rule of bureaucracy as opposed to the rule of the people” and advocated for cutting regulations and government spending to stimulate economic growth, aiming for 4-5% growth without inflation by 2026.


“The overarching goal is to lay the foundation for prosperity that will last many decades, maybe centuries,” Musk added. He stressed the importance of updating government technology, noting that many systems are outdated and inefficient, such as the manual pension system. “The U.S. government needs tech support,” he quipped.


On foreign policy, Musk stated, “America should mind its own business rather than push for regime change,” signaling a shift towards less international interference. He also stressed the need to improve basic education, pointing out the U.S.’s low ranking in the OECD.


Musk also discussed Grok 3.0, his latest AI model set to launch in 1-2 weeks, calling it “scary smart.” He added, “This might be the last time any AI is better than Grok.”


Meanwhile, Joseph Tsai, Chairman of Alibaba Group, a user and admirer of Grok, argued that the value of AI isn’t in having the smartest systems, but in their application in solving real-world problems.


He compared AI development to raising children, emphasizing that not everyone needs the “smartest child.” He predicts that more resources will shift towards practical applications, leveraging open-source tools, which democratize AI development. He added: “Companies big and small can now develop AI together and contribute to the power of AI.”


Beyond AI, both Arvind Krishna, CEO of IBM, and Sundar Pichai, CEO of Google, said they looked forward to the imminent age of quantum computing, which they believe will spearhead the world into a new era.


Pichai said: “Google’s quantum computing performed a computation in five minutes that would take the fastest supercomputer over 10 septillion years.” He compared its current state to AI in the 2010s, predicting practical applications within 5-10 years.


Pichai added that for governments: “It’s too early to regulate the technology, but I think it’s important to come to a good understanding of it and then start preparing for it.”


Technology as the enabler of the new age of healthcare and education


Public healthcare systems also require innovation and new policies, argued experts at the Summit. Addressing key challenges in healthcare, Pascal Soriot, CEO of AstraZeneca, encouraged governments to develop policies that enable early disease diagnostics, improve accessibility, and encourage population-wide adoption.


Soriot stated: “Seventy-five percent of deaths come from diseases that are preventable, yet governments only spend 3% of healthcare budgets on prevention and early diagnosis.” He added that diagnostic centers should run 24/7 to reduce costs and increase accessibility.


He highlighted AI’s role in transforming healthcare, noting that it is already enhancing early diagnostics, such as lung cancer detection from X-rays, and improving efficiency in drug development. While skepticism exists around AI's role in drug design due to limited biological data, its potential in healthcare is promising.


“We are not far away from the days when a simple blood test would enable early diagnostics of cancer at a relatively low cost,” Soriot concluded.


Public-private partnerships and innovative healthcare models could further improve accessibility and cost-efficiency, helping transform global healthcare systems.


This applies beyond just healthcare. Mike Sicilia, Executive Vice President of Oracle, stated: “At the heart of every AI strategy is a data strategy. Helping governments vectorize and aggregate the data is the first step in applied AI, particularly when tailoring it to specific citizen services.”


AI applications in education were also a major focus at the Summit. David Baszucki, CEO of Roblox, explored the potential of AI in educating young users through interactive experiences on the platform. He also emphasized the importance of balancing social connectivity and safety on digital platforms.


He added: “We are at a place where it is way beyond what we imagined. In 20 years, I’m expecting an amazing amount of learning on the platform—for instance, interacting with virtual historical characters.”


Global economic challenges and financial cooperation


In parallel discussions, Kristalina Georgieva, Managing Director of the IMF, alongside finance ministers, international officials, and economic experts, explored the challenges facing the multilateral cooperation system, including rising nationalist and geopolitical trends, climate change, and economic inequality.


Speakers highlighted the need for innovative financing mechanisms and an expanded global financial safety net to address economic crises and support developing countries.


They also underlined the role of technology in strengthening financial systems, aligning global networks to protect against economic crises, and building sustainable frameworks for debt management in vulnerable economies.


For more information, visit worldgovernmentsummit.org.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20250214293771/en/



Permalink

https://www.aetoswire.com/en/news/1402202544726


Contacts

Anna Lagutina

a.lagutina@mcgroup.com


 

Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador


 MILPITAS, Calif. -

Amazfit becomes Thomas’ first Smartwatch Partner


(BUSINESS WIRE)--Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the brand's growing roster of elite athletes. As part of the four-year partnership, Thomas will wear Amazfit smartwatches both on the track during training and in competition, and off the track to monitor sleep and recovery. Moreover, through the Zepp app-based food log, Gabby will have easy access to nutrition-tracking as well.


As the 200m, 4x100m and 4x400m gold medalist, Thomas left the 2024 Paris Olympics as the most decorated U.S. track and field athlete at the Games. Additionally, she holds multiple Diamond League titles and took home two additional Olympic medals - 200m (bronze) and 4x100m (silver) - at the 2020 Tokyo Games. The partnership with Amazfit is Thomas’ first with a smartwatch and gives credence to the benefits data can play on athletic performance.


“I’m really excited to partner with Amazfit because, for me, the little things make all the difference,” said Thomas. “As an athlete, this is the exact type of partnership that will help me continue to get better. It's so important to have objective data on my body—whether it’s tracking my heart rate during a workout, seeing how well I’ve recovered, or understanding how much quality sleep I’m getting. Having a reliable smart wearable brand like Amazfit in my corner is a game-changer."


As part of this exciting partnership, Thomas will enhance her training by incorporating Amazfit's smart wearables analysis into her preparation and recovery to improve performance and help break future records. She will also provide insights and feedback to Amazfit’s development and design teams on product future features and styles.


"We are honored to have Gabby join the Amazfit team," said Wayne Huang, Founder & CEO, Zepp Health. "Her remarkable athletic career and passion for style align closely with our mission to unlock the limits of human potential to ‘Discover Amazing.’ Through this partnership, we will continue to empower athletes to unleash their full potential by rewriting the record books utilizing our advanced smart wearables ecosystem."


Amazfit is committed to creating products that empower holistic health and well-being, and that healthy living requires balance across four key pillars of wellness: physical fitness, sleep, mindfulness and nutrition. Amazfit’s diverse product portfolio includes Active, Cheetah and T-Rex series performance smartwatches, Helio smart ring and the Zepp App, all designed to help athletes and health enthusiasts track and enhance their holistic health. The Zepp App’s latest Food Log feature offers athletes like Thomas an unparalleled ability to bridge the gap between nutrition and fitness, ensuring peak performance and optimal recovery. Whether monitoring heart rate, tracking sleep cycles, or logging meals, Amazfit provides the insights needed to maintain a well-rounded approach to health.


Thomas joins a growing list of Amazfit athletes, including HYROX World Champions Meg Jacoby and Hunter McIntyre, Padel star Bea González and Olympians Morgan Pearson (triathlon) and Yemaneberhan "Yeman" Crippa (5k & 10k).


Explore the full range of Amazfit smart wearables and experience innovation that elevates performance, recovery, and precision at www.amazfit.com.


For more information, please visit Amazfit.com and follow us on Facebook, Instagram, Twitter and YouTube.


About Amazfit


Amazfit, a leading global smart wearable brand focused on health and fitness, is part of Zepp Health (NYSE: ZEPP), a health technology company. Offering a wide selection of smartwatches and bands, Amazfit's brand tagline "Discover Amazing", encourages individuals to break their barriers, and exceed expectations while finding joy in every moment.


Amazfit is powered by Zepp Health's proprietary health management platform that delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals. With outstanding craftsmanship, Amazfit smartwatches have won many design awards, including the iF Design Award and the Red Dot Design Award.


Launched in 2015, Amazfit is today embraced by millions of users. Its products are available in more than 90 countries across the Americas, EMEA, and APAC regions. For more information about Amazfit, visit www.amazfit.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20250213824479/en/



Permalink

https://www.aetoswire.com/en/news/20250213824479r1


Contacts

 

MEDIA CONTACT

Mary Thompson Woodbury

mary.woodbury@zepp.com


 

Friday, February 14, 2025

Kao Corporation Discloses the "Board of Directors' Opinion on Shareholder Proposal and Kao’s Strategy to Enhance Corporate Value"

 TOKYO - Friday, 14. February 2025 AETOSWire 


(BUSINESS WIRE)--Kao Corporation (TOKYO:4452) disclosed its opinion on February 14, 2025, regarding the shareholder proposals submitted by Oasis Japan Strategic Fund Ltd. (“Oasis”) for the 119th Annual General Meeting of Shareholders.

Notice Regarding the Board of Directors' Opinion on a Shareholder Proposals


Additionally, the company has published its response to a statement issued by Oasis in April 2024 in a document titled "Board of Directors' Opinion on Shareholder Proposal and Kao’s Strategy to Enhance Corporate Value."

Board of Directors' Opinion on Shareholder Proposal and Kao's Strategy to Enhance Corporate Value


Kao will continue to pursue highly transparent and effective governance, while at the same time implementing the K27 strategy and making every effort to increase its corporate value.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20250214292652/en/



Permalink

https://www.aetoswire.com/en/news/54206762


Contacts

 

Media inquiries should be directed to:

Public Relations

Kao Corporation

corporate_pr@kao.com

Sandvine Clears Major Milestones Enabling Close of Comprehensive Restructuring

 PLANO, Texas - Friday, 14. February 2025



Sandvine clears final milestones enabling its emergence into an AI-driven software company conducting business in democracies, serving telcos, enterprises, managed service providers and cloud providers


(BUSINESS WIRE)--Sandvine Corporation and certain of its affiliates and subsidiaries (“Sandvine” or the “Company”) today announced that on January 30, 2025, it received formal approval from the Ontario Superior Court of Justice (Commercial List) for its previously announced comprehensive restructuring, clearing the path to emerge from protection under the Companies’ Creditors Arrangement Act (“CCAA”) through a sale of its operations to a set of well-capitalized, newly formed entities. In addition, on February 12, 2025, the Company received recognition and enforcement of the Canadian Court’s order within the United States. The Company plans to execute the restructuring transaction and launch its new brand in the coming weeks.


“Today we announce an important milestone in the Company’s business realignment. We are confident that with the overwhelming support of our investors, customers, and employees, we are positioned for continued success as a technology solutions provider of choice for leading telecom and communications companies across the democratic world,” said Carney Hawks, Chairman of the Board of Sandvine. “We look forward to entering this next chapter, which we are confident will be marked by innovation in best-in-class technology, strong business and financial performance, and outstanding customer service.”


The Company will continue to work closely with stakeholders while focusing on promoting internet freedom and digital rights.


About Sandvine


Sandvine, the App QoE company, offers a portfolio that helps service providers deliver high quality, optimized experiences to consumers and enterprises. Service providers around the world are dealing with the fact that the internet is going dark, due to more encryption in applications and transport protocols. The Sandvine portfolio classifies more than 95% of network traffic into applications, application categories, and content categories, providing QoE scores and persona-guided workflows that address business problems quickly and efficiently. To learn how Sandvine solutions empower service providers globally to analyze, optimize, and monetize application experiences, follow Sandvine on Facebook, LinkedIn, and Twitter.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20250213537768/en/



Permalink

https://www.aetoswire.com/en/news/20250213537768r1


Contacts

 

Media and NGO Contact

pro-sandvine@prosek.com


Customer, Partner, and Supplier Contact

contactus@sandvine.com


 

Pine Island New Energy Partners and Type One Energy Announce Collaboration to Mature Fusion Energy Supply Chain

 KNOXVILLE, Tenn. - Thursday, 13. February 2025



(BUSINESS WIRE)--Pine Island New Energy Partners (PINEP), a private equity firm, and Type One Energy, the leading stellarator fusion company in the market, today announced their strategic collaboration to accelerate the maturation of a more robust supply chain for the fusion energy industry.


As the global fusion sector moves aggressively toward commercialization, the need to refine and scale the supply of specialized components and advanced manufacturing capabilities is more urgent than ever. Through this collaboration, PINEP can better provide the capital and management assistance needed to enable these fusion industry supplier chain companies to meet the needs of the growing fusion industry. The role of Type One Energy is that of an advisory institutional operating partner, working together with PINEP to identify and evaluate companies which have the technology and expertise, such as manufacturing high-temperature superconductors, providing advanced materials, and performing precision manufacturing, to grow and succeed in this emerging market.


“We are excited to partner with Type One Energy to help scale the companies that will enable the commercial fusion industry to thrive,” said Chris Good, Managing Partner at Pine Island New Energy Partners. “Our strategy focuses on growth-stage supply chain companies that produce critical technologies serving both fusion and the broader electrification markets. By working with Type One Energy’s technical team, we can better evaluate and support companies that will be crucial to this transformative industry.”


This announcement follows the recent announcement that the Tennessee Valley Authority (TVA) and Type One Energy will jointly develop and evaluate a fusion power plant project in the Tennessee Valley region, with TVA building and operating the plant using Type One Energy stellarator fusion power technology. The company’s collaboration with PINEP will strengthening the supply chain necessary to build Infinity Two as well as scale the broader fusion industry to meet the more than $1T/year global market demand for 20,000 GW of safe, abundant, clean fusion energy.


“To bring fusion energy to the global energy markets, we need to cultivate an efficient, reliable, and innovative world-wide supply chain,” said Chris Mowry, CEO of Type One Energy. “By partnering with PINEP, we can combine our fusion industry knowledge with their expertise to address this challenge in a more practical way.”


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20250213421850/en/



Permalink

https://www.aetoswire.com/en/news/1302202544655


Contacts

Media Contacts:

For Type One Energy:

Andrea Schneibel

Type One Energy | Marketing and Communications

608-616-5965

andrea.schneibel@typeoneenergy.com


 

Trident et le ministère des Postes, des Télécommunications et des Technologies numériques de la République démocratique du Congo signent un accord pour la mise en œuvre du Système national d’identité numérique

 

SINGAPOUR, 12 févr. 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (« Trident » ou la « Société », NASDAQ : TDTH), un catalyseur majeur de la transformation numérique dans les services d’optimisation technologique et d’activation Web 3.0 basé à Singapour, a annoncé aujourd’hui la signature d’un accord de mise en œuvre avec le ministère des Postes, des Télécommunications et des Technologies numériques de la République démocratique du Congo (« RDC » ou la « République »). Cet accord marque le début du déploiement du Système national d’identité numérique.

Cet accord de collaboration préliminaire détermine le lancement opérationnel d’une plateforme globale d’identification et d’authentification numérique en RDC. Il officialise la collaboration initiale entre Trident et la République démocratique du Congo, qui évolue de la planification stratégique à l’exécution contractuelle.

Cet accord décrit des livrables spécifiques, notamment le développement et le déploiement d’un système intégré de vérification et d’authentification de l’identité numérique basé sur une infrastructure sécurisée pour la fourniture de services gouvernementaux.

En outre, ce système intégrera de solides mesures de protection des données alignées sur les normes internationales afin de garantir la sécurité et la confidentialité des informations des citoyens. Ces éléments fondamentaux visent à révolutionner les interactions entre les citoyens et le gouvernement et marquent ainsi une étape majeure vers une nation numériquement intégrée. Cette technologie profitera également aux citoyens en améliorant l’efficacité et la sécurité des services gouvernementaux, tout en garantissant le contrôle et le consentement des utilisateurs.

Déclarations de l’équipe de direction

Soon Huat Lim, fondateur, président et directeur général de Trident, a déclaré :

« La signature de cet accord représente une étape cruciale dans notre mission de fournir aux citoyens de la RDC des services d’identité numérique sécurisés et accessibles. En travaillant directement avec le ministère des Postes, des Télécommunications et des Technologies numériques, nous mettrons en œuvre des systèmes avancés de vérification et d’authentification de l’identité numérique qui serviront de pierre angulaire à la transformation numérique de la RDC. Cette phase de mise en œuvre se concentrera sur la construction d’une infrastructure robuste afin que chaque citoyen puisse accéder en toute sécurité aux services gouvernementaux grâce à une identité numérique vérifiée. »

Il a ajouté :

« Les systèmes que nous développons établiront de nouvelles normes pour la gouvernance numérique en Afrique, tout en créant un modèle reproductible pour les pays en développement. Ce partenariat est un parfait exemple de la manière dont une technologie innovante peut être exploitée pour générer des changements significatifs dans le quotidien des gens. »

Augustin Kibassa Maliba, ministre des Postes, des Télécommunications et des Technologies numériques de la RDC, a déclaré :

« Le système d’identité numérique est un pilier fondamental de la modernisation de notre pays par le biais de la transformation numérique. Avec Trident, nous serons en mesure de fournir à nos citoyens un accès sécurisé et efficace aux services gouvernementaux, tout en protégeant leurs données personnelles grâce aux progrès de la technologie blockchain. Ce partenariat démontre notre engagement à tirer parti de solutions innovantes dans l’intérêt de tous les Congolais. La mise en œuvre de cette transformation numérique se traduit par la construction d’infrastructures, mais aussi par la création de nouvelles opportunités de croissance économique et d’inclusion sociale. »

À propos de Trident

Basé à Singapour, Trident est un catalyseur pionnier de la transformation numérique dans les secteurs de l’optimisation numérique, les services technologiques et l’activation Web 3.0 à l’échelle mondiale. Cette société propose des solutions numériques commerciales et technologiques conçues pour optimiser l’expérience de ses clients auprès de leurs utilisateurs finaux en favorisant l’adoption du numérique et le libre accès.

Tridentity, son produit phare, est une solution d’identité innovante et hautement sécurisée basée sur la blockchain, conçue pour fournir des capacités d’authentification unique sécurisées aux systèmes tiers intégrés dans divers secteurs. Tridentity entend proposer des fonctionnalités de sécurité inédites afin de garantir la protection des informations sensibles et prévenir les menaces potentielles, promettant ainsi une nouvelle ère sécurisée dans le paysage numérique mondial en général, en Asie du Sud-Est, etc.

Au-delà de Tridentity, la mission de Trident est de devenir le leader mondial de l’activation Web 3.0, en connectant notamment les entreprises à une plateforme technologique fiable et sécurisée, avec des expériences client sur mesure et optimisées.

Clause de non-responsabilité

La présente annonce contient des « déclarations prospectives » (« forward-looking statements ») au sens des dispositions de la « sphère de sécurité » (« safe harbor ») du Private Securities Litigation Reform Act de 1995 des États-Unis. Ces déclarations prospectives peuvent être identifiées par l’emploi de termes tels que « sera », « s’attend », « prévoit », « entend », « futur », « a l’intention », « planifie », « croit », « estime », « susceptible de » et d’autres expressions de même sens. La Société peut également faire des déclarations prospectives écrites ou orales dans ses rapports périodiques à la Securities and Exchange Commission des États-Unis (la « SEC »), dans son rapport annuel aux actionnaires, dans des annonces et autres documents écrits, ainsi que dans des déclarations orales faites par ses dirigeants, administrateurs ou employés à des tiers. Les déclarations ne relevant pas de faits historiques, y compris les déclarations concernant les convictions, les projets et les attentes de la Société, constituent des déclarations prospectives. Les déclarations prospectives impliquent des risques et des incertitudes inhérents, y compris la possibilité qu’un accord définitif ne soit pas conclu comme le prévoit l’accord de collaboration préliminaire évoqué dans la présente annonce, et la possibilité que le système e-GOV ne se concrétise pas comme le prévoit l’accord de collaboration préliminaire ou un accord définitif éventuellement conclu. En raison d’un certain nombre de facteurs, les résultats réels pourraient différer sensiblement de ceux contenus dans des déclarations prospectives, y compris, sans toutefois s’y limiter, les éléments suivants : les stratégies, le développement commercial futur, la situation financière et les résultats d’exploitation de la Société ; la croissance attendue du marché des solutions numériques ; les évolutions politiques, économiques, sociales et juridiques dans les juridictions où la Société opère ou dans lesquelles la Société a l’intention de développer ses activités et ses opérations ; la capacité de la Société à maintenir et à améliorer sa marque. De plus amples informations concernant ces risques et d’autres risques sont incluses dans les documents déposés par la Société auprès de la SEC. Toutes les informations contenues dans la présente annonce sont fournies à la date des présentes, et la Société décline toute obligation de mettre à jour les déclarations prospectives, sauf si la loi applicable l’exige.

Contacts investisseurs et médias

Relations avec les investisseurs
Robin Yang, Associé
ICR, LLC
E-mail : investor@tridentity.me 
Téléphone : +1 (212) 321-0602

Relations avec les médias
Brad Burgess, Vice-président principal
ICR, LLC
E-mail : Brad.Burgess@icrinc.com 

Une photo accompagnant la présente annonce est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/1627fdde-b97d-48f2-b2b9-f50149c37570


Copyright © 2025 GlobeNewswire, Inc.

Trident and the Ministry of Posts, Telecommunications, and Digital Technology of the Democratic Republic of the Congo Sign an Agreement for the Implementation of the National Digital Identity System

 

SINGAPORE, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today announced the signing of an implementation agreement with the Ministry of Posts, Telecommunications, and Digital Technology of the Democratic Republic of the Congo (“DRC” or the “Republic”). This agreement marks the beginning of the deployment of the national digital identity system.

This preliminary collaboration agreement signifies the operational launch of a comprehensive digital identification and authentication platform in the DRC. It formalizes the initial collaboration between Trident and the Democratic Republic of the Congo, transitioning from strategic planning to contractual execution.

The agreement outlines specific deliverables, including the development and deployment of an integrated digital identity verification and authentication system based on a secure infrastructure for delivering government services.

Furthermore, the system will incorporate robust data protection measures aligned with international standards, ensuring the security and confidentiality of citizens’ information. These fundamental elements aim to revolutionize interactions between citizens and the government, marking a major step toward a digitally integrated nation. This technology will also benefit citizens by enhancing the efficiency and security of government services while ensuring user control and consent.

Statements from Leadership

Soon Huat Lim, Founder, Chairman, and Chief Executive Officer of Trident, stated:

“The signing of this agreement represents a crucial milestone in our mission to provide the citizens of the DRC with secure and accessible digital identity services. By working directly with the Ministry of Posts, Telecommunications, and Digital Technology, we will implement advanced digital identity verification and authentication systems that will serve as the cornerstone of the DRC’s digital transformation. This implementation phase will focus on building a robust infrastructure, ensuring that every citizen can securely access government services through a verified digital identity.”

He added:

“The systems we are developing will establish new standards for digital governance in Africa while creating a replicable model for developing nations. This partnership is a prime example of how innovative technology can be leveraged to drive meaningful change in people’s daily lives.”

H.E. Augustin Kibassa Maliba, Minister of Posts, Telecommunications, and Digital Technology of the DRC, commented:

“The Digital Identity System is a key pillar in modernizing our country through digital transformation. With Trident, we will be able to provide our citizens with secure and efficient access to government services while protecting their personal data through advancements in blockchain technology. This partnership demonstrates our commitment to leveraging innovative solutions for the benefit of all Congolese. By implementing this digital transformation, we are not only building infrastructure but also creating new opportunities for economic growth and social inclusion.”

About Trident

Trident is a leading catalyst for digital transformation in digital optimization, technology services, and Web 3.0 activation worldwide based in Singapore. The Company offers commercial and technological digital solutions designed to optimize its clients’ experience with their end-users by promoting digital adoption and self-service.

Tridentity, the Company’s flagship product, is an innovative and highly secure blockchain-based identity solution designed to provide secure single sign-on authentication capabilities to integrated third-party systems across various industries. Tridentity aims to offer unparalleled security features, ensuring the protection of sensitive information and preventing potential threats, thus promising a new secure era in the global digital landscape in general, and in Southeast Asia etc.

Beyond Tridentity, the Company’s mission is to become the global leader in Web 3.0 activation, notably connecting businesses to a reliable and secure technological platform, with tailored and optimized customer experiences.

Safe Harbor Statement

This announcement contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in announcements and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about the Company’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, including the possibility that a definitive agreement will not be concluded as contemplated under the preliminary collaboration agreement discussed in this announcement, and the possibility that the e-GOV system will not materialize as contemplated under the preliminary collaboration agreement or a definitive agreement if and once concluded. A number of factors could also cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s strategies, future business development, and financial condition and results of operations; the expected growth of the digital solutions market; the political, economic, social and legal developments in the jurisdictions that the Company operates in or in which the Company intends to expand its business and operations; the Company’s ability to maintain and enhance its brand. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this announcement is as of the date of this announcement, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Investor and Media Contacts

Investor Relations
Robin Yang, Partner
ICR, LLC
Email: investor@tridentity.me
Phone: +1 (212) 321-0602

Media Relations
Brad Burgess, SVP
ICR, LLC
Email: Brad.Burgess@icrinc.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1627fdde-b97d-48f2-b2b9-f50149c37570


Copyright © 2025 GlobeNewswire, Inc.

Kinaxis Settles Pending Litigation

OTTAWA, Ontario - Thursday, 13. February 2025

(BUSINESS WIRE)--Kinaxis® (TSX: KXS), a global leader in end-to-end supply chain orchestration, has entered into a settlement agreement with Blue Yonder Group, Inc. to fully resolve all pending litigation matters between the companies which includes Blue Yonder’s patent infringement claims and Kinaxis’ trade secret misappropriation counterclaims.

The terms of the settlement agreement are confidential.

About Kinaxis

Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™ combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Forward-Looking Information

Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to Kinaxis' growth opportunities and the potential benefits of, and demand for, Kinaxis’ products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis' products and services compared to competitive offerings in the industry. Readers are cautioned not to place undue reliance on such statements. Kinaxis' actual results, performance, achievements and developments may differ materially from the results, performance, achievements or developments expressed or implied by such statements. Risk factors that may cause the actual results, performance, achievements or developments of Kinaxis to differ materially from the results, performance, achievements or developments expressed or implied by such statements can be found in the public documents filed by Kinaxis with Canadian securities regulatory authorities. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250213527029/en/

Permalink
https://www.aetoswire.com/en/news/1302202544638

Contacts

Media Relations
Belinda Thomas | Kinaxis
bthomas@kinaxis.com
+1 613 322 9305

Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
613-907-7613

The smarter E Europe: Smart Integration Saves Cash and Stabilizes Grids

 MUNICH & PFORZHEIM, Germany - Thursday, 13. February 2025 AETOSWire

(BUSINESS WIRE)--‘Accelerating Integrated Energy Solutions’ - this is the motto of The smarter E Europe 2025, which will take place this year from 7 to 9 May at Messe München. Smart integration is crucial in the evolving energy and mobility sectors. Energy management systems (EMS) for prosumers and businesses have shifted from a nice-to-have to a must-have, making them a key topic at this year’s event.

GridX, a smart energy company, estimates that the European Home Energy Management System (HEMS) market will expand 11-fold by 2030 across Denmark, Germany, the UK, Italy, the Netherlands, Austria, Sweden, and Spain. This rapid growth reflects increasing demand and evolving regulations.

Regulatory and market requirements

Regulations such as Section 14a of Germany’s Energy Industry Act (EnWG) allow grid operators to control the power output of heat pumps, EV chargers, and battery storage systems. A robust EMS can optimize energy use, reducing reliance on the grid without compromising user comfort.

The challenge of interoperability

Interoperability remains a challenge, with ongoing discussions about standardization. Manufacturer-independent solutions allow greater flexibility for customers. At The smarter E Europe, top industry leaders will address interoperability concerns, emphasizing open standards. In 2018, the OpenEMS Association took a leading role in supporting efforts to create open and manufacturer-independent standards for energy management systems. OpenEMS is not a communication protocol, such as EEBus, but a software platform. The Association counts universities and research institutes, grid operators and industry associations as well as energy management companies among its members.

Focus event hosted by pv magazine and The smarter E Forum

Home energy management is also going to be discussed at the focus event hosted by pv magazine on the second exhibition day, May 8, 2025. Two interactive sessions will shed light on key aspects of quality photovoltaics and storage projects in the small and utility-scale sectors. pv magazine invites interested visitors to ICM – International Congress Center Messe München, room 13, from 1:00pm–5:00pm. It will be held in German. A separate, English-speaking session aimed at an international expert audience will focus on optimizing large-scale storage systems and the quality assurance of planning, design and marketing. Click here to register for the event.

The smarter E Forum will be organizing a dedicated session for prosumer home energy management systems. On Friday, May 9, the key role of HEMS for modern energy management and grid stability will be discussed starting from 1:30pm.

Munich becomes the center of the energy world

In May, at Messe München, innovation will meet practice, and visions will meet concrete solutions. The smarter E Europe shows how the sectors electricity, heat and transportation can be intelligently connected to create a decentralized, digitalized and flexible energy world. From May 7–9, 2025, Messe München is fully booked – the organizers expect more than 3,000 exhibitors and over 110,000 visitors at the exhibition ground covering 206,000 square meters across 19 exhibition halls and the Outdoor Area.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250212149082/en/

Permalink
https://www.aetoswire.com/en/news/1302202544617

Contacts

Press contact:
ressourcenmangel an der Panke GmbH | Schlesische Straße 26/c4 |10997 Berlin
Roberto Freiberger | Tel.: +49 163 8430 943
roberto.freiberger@ressourcenmangel.de

Solar Promotion GmbH | Postfach 100 170 | 75101 Pforzheim
Peggy Härter-Zilay | Tel.: +49 7231 58598-240
zilay@solarpromotion.com


Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis

 ZUG, Switzerland - Friday, 14. February 2025 AETOSWire

Ad hoc announcement pursuant to Art. 53 LR

    This approval from the European Commission is based on robust results from the phase III OLYMPIA and ARCADIA clinical trial programs, showing that Nemluvio has the potential to address the significant unmet needs of patients with atopic dermatitis and prurigo nodularis1-3
    There is a need for new treatment options for atopic dermatitis and prurigo nodularis to effectively relieve the signs and symptoms such as persistent itch, skin lesions and poor sleep quality4-8
    Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives itch and is involved in inflammation and skin barrier dysfunction in both atopic dermatitis and prurigo nodularis, and fibrosis in prurigo nodularis5,8-10
    Nemluvio is the first monoclonal antibody in Galderma’s portfolio of innovative, science-based products, which span the full spectrum of the fast-growing dermatology market

 

(BUSINESS WIRE)--Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now approved for subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older who are candidates for systemic therapy, and for subcutaneous use for the treatment of adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy.11

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213843444/en/

 

“Throughout Galderma’s four decades in dermatology we have consistently worked to meet the needs of patients and deliver first-in-class treatment options. This has been exemplified through the clinical and regulatory success achieved with our unique monoclonal antibody, Nemluvio. As the first biologic treatment in our Therapeutic Dermatology portfolio, Nemluvio shows our commitment to advancing dermatology by expanding into new areas of need.”

FLEMMING ØRNSKOV, M.D., MPH
CHIEF EXECUTIVE OFFICER
GALDERMA

 
    

 

Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31.9 IL-31 is a neuroimmune cytokine that drives itch and is involved in inflammation and skin barrier dysfunction in both atopic dermatitis and prurigo nodularis, and fibrosis in prurigo nodularis.5,8-10 It is also the first and only biologic approved for atopic dermatitis and prurigo nodularis with four-week dosing intervals from the start of treatment.11

This approval is based on results from the phase III ARCADIA and OLYMPIA clinical trial programs, in which Nemluvio significantly improved itch, skin lesions and sleep disturbance, in patients with moderate-to-severe atopic dermatitis and adults with prurigo nodularis, respectively.1-3

Results from the ARCADIA 1 and ARCADIA 2 trials demonstrated that patients treated with Nemluvio, administered subcutaneously every four weeks in combination with background topical corticosteroids, with or without topical calcineurin inhibitors (+TCS/TCI), showed statistically significant improvements on skin clearance in both co-primary endpoints at Week 16, when compared to placebo +TCS/TCI.1 The trials also met all key secondary endpoints, confirming significant responses on itch as early as Week 1 and statistically significant improvements in sleep disturbance.1

Both co-primary endpoints were also met in the OLYMPIA 1 and OLYMPIA 2 clinical trials, where Nemluvio monotherapy demonstrated significant and clinically meaningful improvements on itch and skin lesions at Week 16, when compared to placebo.2,3 The trials met all key secondary endpoints, showing rapid reduction in itch due to prurigo nodularis and sleep disturbance within four weeks of treatment initiation.2,3

Nemluvio was well tolerated in all trials, and its safety profile was generally consistent with earlier data, and between trials.1-3

 

“Atopic dermatitis and prurigo nodularis can severely impact quality of life due to the associated debilitating symptoms, including chronic itch, skin lesions, poor sleep quality and mental health conditions. With this approval, patients in the EU have a new treatment option, which extensive data has shown can help to safely, quickly, and effectively ease the key symptoms of these diseases and therefore the burden on patients’ lives.”

PROFESSOR DIAMANT THAÇI
LEAD INVESTIGATOR OF THE ARCADIA STUDIES IN EUROPE
UNIVERSITY OF LUBECK, GERMANY

 
    

 

 

“Nemolizumab’s benefits have been demonstrated in its comprehensive clinical trial programs in both atopic dermatitis and prurigo nodularis, including the OLYMPIA 1 and 2 studies, which make up the largest completed pivotal program in prurigo nodularis to date. These clinical data, plus its first-in-class mechanism of action and convenient dosing schedule, make it an important new therapeutic solution for dermatologists to support their patients.”

PROF. SONJA STÄNDER
LEAD INVESTIGATOR OF THE OLYMPIA STUDIES IN EUROPE
UNIVERSITY HOSPITAL MÜNSTER, GERMANY

 
    

 

Nemluvio is also approved by the U.S. Food and Drug Administration for the treatment of atopic dermatitis and prurigo nodularis.12 It is under review for the treatment of both diseases by several additional regulatory authorities around the world, including Canada, Brazil, and South Korea, and via the Access Consortium framework in countries such as Australia, Singapore and Switzerland. Further submissions to other regulatory authorities are ongoing.

As previously communicated, peak sales of Nemluvio are expected to reach more than 2 billion USD (expected beyond the 2023-2027 mid-term guidance period). Galderma anticipates Nemluvio to approach ‘blockbuster’ net sales run-rate by the end of 2027.

Media can find more information about atopic dermatitis and prurigo nodularis here.

About Nemluvio

Nemluvio was initially developed by Chugai Pharmaceutical Co., Ltd. In 2016, Galderma obtained exclusive rights to the development and marketing of nemolizumab worldwide, except in Japan and Taiwan. In Japan, nemolizumab is marketed as Mitchga® and is approved for the treatment of prurigo nodularis, as well as pruritus associated with atopic dermatitis in pediatric, adolescent, and adult patients.13,14

About the ARCADIA clinical trial program1,15,16

The ARCADIA program included two identically designed, pivotal phase III clinical trials, which enrolled more than 1,700 patients – ARCADIA 1 and ARCADIA 2.

These global, randomized, multicenter, double-blind, placebo-controlled phase III clinical trials evaluated the efficacy and safety of nemolizumab administered subcutaneously every four weeks compared to placebo (both administered with background topical corticosteroids with or without topical calcineurin inhibitors).

The trials were conducted in adolescent and adult patients (12 years and over) with moderate-to-severe atopic dermatitis for an initial treatment phase of 16 weeks. Patients who responded to treatment (defined as patients who achieved an investigator’s global assessment score of clear (0) or almost clear (1), or a 75% or greater improvement in the eczema area and severity index score) were then re-randomized to a maintenance treatment phase for up to 48 weeks.

About atopic dermatitis

Atopic dermatitis is a common, chronic, and flaring inflammatory skin disease, characterized by persistent itch and recurrent skin lesions.5,17,18 It is the most common inflammatory skin disease, impacting almost four times more people than psoriasis.5,19 It affects approximately 10 to 40 million people in the European Union, with up to 66% of adults suffering with a moderate-to-severe form of the condition.20,21 While currently available treatments may improve some signs and symptoms of the disease, many patients do not respond optimally to approved therapies and do not experience itch relief and clear skin to the same degree.5-8

About the OLYMPIA clinical trial program2,3,22,23

The OLYMPIA program included two identically designed, pivotal phase III clinical trials which enrolled 560 patients – OLYMPIA 1 and OLYMPIA 2. This is the largest clinical trial program conducted in prurigo nodularis to date, and the only program to include a long-term extension study.

These global, randomized, double-blind, placebo-controlled phase III clinical trials assessed the efficacy and safety of nemolizumab monotherapy compared with placebo in patients at least 18 years of age with moderate-to-severe prurigo nodularis over a 16- or 24-week treatment period for OLYMPIA 2 and OLYMPIA 1, respectively.

About prurigo nodularis

Prurigo nodularis is a chronic, debilitating, and distinct neuroimmune skin disease characterized by the presence of intense itch and thick skin nodules covering large body areas.24-26 It is estimated to affect between 7-111 people per 100,000 in the European Union depending on the country.27,28 The majority of patients report that the persistent itch negatively impacts their quality of life.29 Furthermore, the intense itch associated with prurigo nodularis results in significant sleep disturbance and further contributes to reduced quality of life.30,31

About Galderma

Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

    Silverberg J, et al. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 & 2): results from two replicate double-blinded, randomised controlled phase 3 trials. Lancet. 2024;404(10451):445-460. doi: 10.1016/S0140-6736(24)01203-0
    Kwatra SG, et al. Placebo-controlled phase III trial of nemolizumab in patients with prurigo nodularis. N Engl J Med. 2023;389:1579-89. doi: 10.1056/NEJMoa2301333
    Ständer S, et al. Nemolizumab in Patients with Moderate-to-Severe Prurigo Nodularis: A Randomized Controlled Phase 3 Trial. JAMA Derm. 2024;160. doi: 10.1001/jamadermatol.2024.4796
    Chisolm SS. A Review of the Current Management and Burden of Prurigo Nodularis in the United States. AJMC. 2023; 2023;29(suppl 5):S63-S72. doi.org/10.37765/ajmc.2023.89366
    Langan SM, et al. Atopic dermatitis [published correction appears in Lancet. 2020;396(10253):758]. Lancet. 2020;396(10247):345-360. doi:10.1016/S0140- 6736(20)31286-1
    Lobefaro F, et al. Atopic Dermatitis: Clinical Aspects and Unmet Needs. Biomedicines. 2022;10:2927. doi:10.3390/biomedicines10112927
    Katoh N, Ohya Y, Ikeda M, et al. Clinical practice guidelines for the management of atopic dermatitis 2018. J Dermatol. 2019;46(12):1053-1101. doi:10.1111/1346-8138.15090
    Kwatra SG, Misery L, Clibborn C, Steinhoff M. Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics. Clin Transl Immunology. 2022;11(5):e1390. doi:10.1002/cti2.1390
    Silverberg JI, et al. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus. J Allergy Clin Immunol. 2020;145(1):173-182. doi:10.1016/j.jaci.2019.08.013
    Bewley A, et al. Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments. Dermatol Ther (Heidelb). 2022;12(9):2039–2048. doi:10.1007/s13555- 022-00782-2
    Nemluvio. EU Summary of Product Characteristics 2025
    NEMLUVIO (nemolizumab-ilto) injection 30 mg Prescribing Information. Dallas, TX: Galderma Laboratories, L.P.; August 2024
    Chugai Pharmaceutical Co., Ltd. Maruho Obtained Regulatory Approval for Mitchga, the first Antibody Targeting IL-31 for Itching Associated with Atopic Dermatitis. Available online. Accessed February 2025
    Chugai Pharmaceutical Co., Ltd. Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcutaneous Injection 30mg Vials. Available online. Accessed February 2025
    ClinicalTrials.Gov. Efficacy & Safety of Nemolizumab in Subjects With Moderate- to-Severe Atopic Dermatitis (NCT03985943). Available online. Accessed February 2025
    ClinicalTrials.Gov. Efficacy & Safety of Nemolizumab in Subjects With Moderate- to-Severe Atopic Dermatitis (NCT03989349). Available online. Accessed February 2025
    Yang G, et al. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis. Int J Mol Sci. 2020;21(8):2867. doi: https://doi.org/10.3390/ijms21082867
    Ständer S. Atopic dermatitis. N Engl J Med. 2021;384(12):1136-1143. doi:10.1056/NEJMra2023911
    Raharja A, et al. Psoriasis: a brief overview. Clin Med (Lond). 2021;21(3):170-173. doi: 10.7861/clinmed.2021-0257
    Luger, T, et al. Clinical and Humanistic Burden of Atopic Dermatitis in Europe: Analyses of the National Health and Wellness Survey. Dermatol Ther (Heidelb). 2022;12:949–969. https://doi.org/10.1007/s13555-022-00700-6
    Oisín S, et al. 545 - Prevalence of moderate and severe atopic dermatitis in Ireland: a cross-sectional, real-world study of a secondary care population. BJD. 2024;190(S2):ii43–ii44. https://doi.org/10.1093/bjd/ljad498.045
    ClinicalTrials.Gov. An Efficacy and Safety Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (NCT04501679). Available online. Accessed February 2025
    ClinicalTrials.Gov. Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) (NCT04501666). Available online. Accessed February 2025
    Huang AH, et al. Prurigo nodularis: epidemiology and clinical features. J Am Acad Dermatol. 2020;83(6):1559-1565. doi:10.1016/j.jaad.2020.04.183
    Pereira MP, et al. European Academy of Dermatology and Venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018;32(7):1059-1065. doi:10.1111/jdv.14570
    Ständer S, et al. IFSI-guideline on chronic prurigo including prurigo nodularis. Itch. 2020;5(4):e42. doi:10.1097/itx.0000000000000042
    Ryczek A, et al. Prevalence of Prurigo Nodularis in Poland. Acta Derm Venereol. 2020;100:adv00155. doi: 10.2340/00015555-3518
    Ständer, S, et al. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis. Acta Dermato-Venereologica. 2020;100(18):1–6. https://doi.org/10.2340/00015555-3655
    Todberg T, et al. Treatment and burden of disease in a cohort of patients with prurigo nodularis: a survey-based study. Acta Derm Venereol. 2020;100(8):adv00119. doi:10.2340/00015555-3471
    Joel MZ, et al. Risk of itch-induced sleep deprivation and subsequent mental health comorbidities in patients with prurigo nodularis: A population-level analysis using the Health Improvement Network. E-poster presented at EADV 2023. Abstract available online
    Kwatra SG. Breaking the itch–scratch cycle in prurigo nodularis. N Engl J Med. 2020;382(8):757-758. doi:10.1056/NEJMe1916733

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250213843444/en/

Permalink
https://www.aetoswire.com/en/news/1402202544700

Contacts

For further information:

Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Sébastien Cros
Corporate Communications Director
sebastien.cros@galderma.com
+41 79 529 59 85

Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12

Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43

Dubai achieves world’s lowest electricity Customer Minutes Lost (CML) at 0.94 minutes per year, breaking its 2023 record

 

Dubai, United Arab Emirates, 12 February 2025: HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA), announced that DEWA achieved the world’s lowest electricity Customer Minutes Lost (CML) in 2024, recording just 0.94 minutes per customer. This breaks its record of 1.06 minutes in 2023 and is significantly lower than the 15-minute average of leading European utilities.

"We are guided by the vision and directives of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to make Dubai the world’s best city for quality of life. To achieve this, we continuously develop Dubai's electricity and water infrastructure through innovation, which we adopt as a key approach to managing facilities through a smart and interconnected network. This enables us to deliver our services according to the highest standards of quality, availability, reliability, efficiency and sustainability, supporting the Dubai 2040 Urban Master Plan and the Dubai Economic Agenda (D33), which aims to position Dubai among the world’s top three cities. We have reduced the Customer Minutes Lost in Dubai from 6.88 minutes per year in 2012 to just 0.94 minutes in 2024. This emphasises our leadership in innovation and adopting the latest disruptive technologies of the Fourth Industrial Revolution to enhance DEWA’s resilience, agility and readiness to meet the growing demand for electricity and water in Dubai," said HE Saeed Mohammed Al Tayer.

"The Smart Grid, which we are implementing in stages with AED 7 billion investments up to 2035, has been instrumental in achieving this milestone. It provides advanced features, including enhanced energy transmission and distribution efficiency, reduced losses and improved electric load management. A key programme launched under the Smart Grid is the Automatic Smart Grid Restoration System, the first of its kind in the Middle East and North Africa. It increases the control, management and monitoring of the power network. Operating around the clock without human intervention, it uses smart, innovative and centralised systems to locate faults, isolate them and automatically restore service, enhancing grid automation, fault detection and rapid service restoration," added Al Tayer.

 

 

*Source: AETOSWire

 

Contacts:

Shaikha Almheiri

Dubai Electricity and Water Authority

+971552288228

shaikha.almheiri@dewa.gov.ae